News

Primary open-angle glaucoma is generally associated with elevations in IOP, and damage to the cells residing within the trabecular meshwork is most likely a contributing factor, said Markus H. Kuehn, PhD.

Long-term results reveal that intravitreal ranibizumab (Lucentis, Genentech) has made a marked difference in the rates of blindness related to wet age-related macular degeneration (AMD), said Peter Cackett, MB BS.

The addition of the carotenoids, lutein and zeaxanthin, and the omega-3 fatty acids, DHA and EPA, to a supplement formulation does not further reduce the risk of disease progression in age-related macular degeneration (AMD), said Emily Y. Chew, MD.

The results of the long-awaited Age-Related Eye Disease Study 2 (AREDS2) were officially released Sunday afternoon during a special session at the Association for Research in Vision and Ophthalmology meeting in Seattle-and the study results really did not come as a surprise to most in the eye-care community.

Lens assessment with femtosecond laser imaging offers opportunity for cataract outcomes

Making a diagnosis is only the first step in treating dry eye syndrome

Pre-emptive strategies for exacerbations guided by seasonal fluctuations

Pre-existing dry eye should be identified and controlled before surgery is considered

Two cases illustrate benefits in managing dry eye before, after surgery with premium lens implantation

LASIK can be an option after management to normalize ocular surface

Challenging cases achieve good refractive outcomes with intraoperative aberrometry

Phase III study of RPE65 for Leber’s congenital amaurosis under way, among other research

SLO-MP shows higher structure/function correlation compared with standard perimetry

Management requires aggressive therapy of inflammation, medical therapy of elevated IOP

Phase III study of RPE65 for Leber’s congenital amaurosis under way, among other research

Man has 3-day history of OD pain, decreased vision, other symptoms: What is diagnosis?

Why unintended consequences can have bad results

Why an effective campaign must be readily available for physicians to implement

Avoiding hypotropia, excyclotropia after augmented transposition surgery among tips

The journey to achieving the perfect lens calculation is now just a few years away from reaching its destination.

The FDA has approved Simbrinza suspension (Alcon) for the reduction of elevated IOP in patients with primary open-angle glaucoma or ocular hypertension.

A team of scientists reports that it has found a way to isolate retinal pigment epithelium cells from human pluripotent stem cells as early as 14 days following the onset of differentiation.

The Tecnis toric 1-piece IOL (Abbott) has received FDA approval, and the company is launching the lens in the United States for treatment of cataract patients with pre-existing corneal astigmatism.

Three keynote speakers, including two Nobel laureates, will present lectures during the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) May 5 to 9 at the Washington State Convention Center. This year, the ARVO/Alcon Keynote Series will include Oliver Smithies, DPhil, Roger Tsien, PhD, and Christopher Murray, MD, DPhil.

With a change of venue and scenery, the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) hits the road this year, moving from its long-time home in Fort Lauderdale, FL, to Seattle. With a central theme of “Life-changing research,” the 2013 conference will focus on how vision researchers make a difference.

Attendees of the 2013 meeting of the Association for Research in Vision and Ophthalmology (ARVO) will want to make time for three special sessions at the Washington State Convention Center. These sessions include results from the Age-Related Eye Disease Study 2 (AREDS2), Inhibition of VEGF in Age-related Choroidal Neovascularisation 2 (IVAN2) Study, and Groupe d’Evaluation Français Avastin versus Lucentis (GEFAL) Study, as well as the National Eye Institute audacious goals initiative.

Corneal crosslinking using the current technique is safe and effective for stabilizing eyes with progressive corneal ectasia, but new treatment protocols and new indications are emerging.

Cartridges pre-loaded by an eye bank (EndoGlide, Angiotech Pharmaceuticals Inc.) have been successfully used in corneal transplantation.

Edward Peterson, president and chief executive officer of AcuFocus Inc., will resign from the company effective April 30, 2013.

Leica Microsystems and Bausch + Lomb have announced that Bausch + Lomb will distribute Leica ophthalmic surgical microscopes and accessories in select markets.